Related Experiment Video
Updated: Feb 14, 2026

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
Published on: November 8, 2016
Advancing Pharmacoequity Globally: Reflections from the ASCPT Development, Regulatory, and Outcomes Network
Priya Jayachandran1, Mayur K Ladumor2, Georgios Vlasakakis3
1Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.
None:
ASCPT has a mission to advance clinical pharmacology and translational sciences to reduce health disparities. The development, regulatory, and outcomes (DRO) network within ASCPT strives to advance pharmacoequity globally. Pharmacoequity, coined by Utibe Essien (2021), is the principle that all individuals, regardless of race, ethnicity, geography, or socioeconomic status, should have access to high-quality and evidence-based therapies. This perspective spotlights the network's contributions toward this goal and identifies priority areas to build equitable health outcomes.
More Related Videos
Related Concept Videos
Global Regulatory Systems
Cis-regulatory Sequences
Cis-regulatory Sequences
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Global Climate Change
Reflection of Waves

